Corcept Therapeutics' GAAP net income for 2021 was $112.512 million, up 6.1% from $106.011 million in the prior year. Revenue increased 3.4% to $365.978 million from $353.874 million a year earlier.
Corcept Therapeutics' GAAP net income for 2021 was $112.512 million, up 6.1% from $106.011 million in the prior year. Revenue increased 3.4% to $365.978 million from $353.874 million a year earlier. 
ir.corcept.com
English (US) 